Hyalgan wani bayani ne mai ban mamaki wanda ya ƙunshi hyaluronate sodium mai tsabta (Hyalectin) a cikin salin physiological. Hyalgan yana daya daga cikin hyaluronates da aka yi amfani da shi don maganin maganin ciki - magani wanda ya hada da inject da wani abu mai gel (hyaluronate) a cikin haɗin haɗin don haɓaka abubuwan da suka shafi visa na ruwa na synovial . Maganin da aka yi wa ƙuƙwalwa yana taimakawa wajen haɗuwa da haɗin gwiwa kuma yana bada lubrication don rage ragewar da ke faruwa tare da motsi.
Tare da osteoarthritis , ruwan gine-ginen ya rasa dukiyarsa na lubricating kuma manufar viscosuplationation shine mayar da waɗannan kaddarorin.
Indiya ga Hyalgan
Hyalgan ya amince da ita ta Cibiyar Abinci da Druggun Amurka (FDA) a ranar 28 ga watan Mayu, 1997, a matsayin wani zaɓi don maganin ciwon osteoarthritis . An dauki magani, ba magani ba. Sulaiman hyaluronate a Hyalgan an fitar da shi daga zane-zane. An nuna Hyalgan ga marasa lafiya da ciwon da ke da alaka da osteoarthritis na gwiwa wadanda basu gaza samun taimako tare da maganin jiyya ba tare da magani ba tare da maganin analgesics mai sauki, irin su acetaminophen .
Gudanarwa na Hyalgan
Hyalgan wata magunguna ne da aka ba da ita sau daya a mako, daya mako daya, domin jimlar 5 injections. Wasu marasa lafiya zasu iya cimma nasara bayan 3 cycles, bisa ga sakamakon bincike na marasa lafiya da suka sami 3 injections sannan kuma an bi su zuwa kwanaki 60.
Tsanani da gargadi
Akwai tsare-tsaren da yawa da gargadi da ke hade da Hyalgan na injections:
- Tsaro da tasiri na Hyalgan a cikin kwakwalwa banda gwiwa ba a taɓa nazarin su ba.
- Idan mai haƙuri yana da ƙwayar cuta ga proteins avian, gashin fuka, ko qwai, dole a yi allurar da hankali.
- Akwai ciwo ko kumburi da allurar da za ta ci gaba. Ana ba da shawara, kamar yadda dukkanin injections ke ciki, wadanda marasa lafiya ba su shiga aiki mai tsanani ko nauyi ba don tsawon awa 48 bayan allura.
- Tsaro da tasiri na hawaye Hyalgan ba a kafa su a cikin mata masu ciki ba, kuma ba a lalata mata. Ba a yi amfani da ita ba a cikin yara.
Hanyoyin Gaba da Matsalar Abin Nuna
Hanyoyin da ke tattare da halayen Hyalgan sun haɗa da matsalolin gastrointestinal, ciwon gurasar injection, ƙusar gwiwa ko gushewa, fatar jiki na fata, da guji, da ciwon kai. Yawancin cututtukan da ke tattare da su shine ingancin gubar da ke cikin bayanan 'yan kwanaki, musamman tare da hutawa da kuma yin amfani da kankara. Dole a biya hankali ga bayyanar cututtuka wanda ya ci gaba kuma yana iya nuna alamar wani abu mai tsanani, irin su kamuwa da cuta ko rashin lafiyar jiki. Irin wannan mummunan abubuwan da ake gani suna da muhimmanci.
Layin Ƙasa
Hyalgan ita ce farkon da FDA ta amince da shi a watan Mayun 1997. Sauran abubuwan da suka dace da FDA, tare da ranar da aka amince da su, sun haɗa da:
- Synvisc 08/08/1997
- Supartz 01/24/2001
- Orthovisc 02/05/2004
- Euflexxa 12/03/2004
Source:
Hyalgan (Sarkar Hyaluronate). Bayyana Bayani. Fidia Pharma Amurka. Revised May 2014.